[go: up one dir, main page]

ATE67406T1 - Nicorandil enthaltende zubereitung zum einspritzen. - Google Patents

Nicorandil enthaltende zubereitung zum einspritzen.

Info

Publication number
ATE67406T1
ATE67406T1 AT87100334T AT87100334T ATE67406T1 AT E67406 T1 ATE67406 T1 AT E67406T1 AT 87100334 T AT87100334 T AT 87100334T AT 87100334 T AT87100334 T AT 87100334T AT E67406 T1 ATE67406 T1 AT E67406T1
Authority
AT
Austria
Prior art keywords
preparation
nicorandil
freeze
dissolved
dried
Prior art date
Application number
AT87100334T
Other languages
English (en)
Inventor
Kouji Ishihara
Mika Sanada
Naoki Matsuo
Yoshimitsu Iida
Yoshinori Matsuoka
Junko Matsuo
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE67406T1 publication Critical patent/ATE67406T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87100334T 1986-01-14 1987-01-13 Nicorandil enthaltende zubereitung zum einspritzen. ATE67406T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP574286 1986-01-14
EP87100334A EP0236679B1 (de) 1986-01-14 1987-01-13 Nicorandil enthaltende Zubereitung zum Einspritzen

Publications (1)

Publication Number Publication Date
ATE67406T1 true ATE67406T1 (de) 1991-10-15

Family

ID=11619552

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100334T ATE67406T1 (de) 1986-01-14 1987-01-13 Nicorandil enthaltende zubereitung zum einspritzen.

Country Status (12)

Country Link
US (1) US4769381A (de)
EP (1) EP0236679B1 (de)
JP (1) JPH0713018B2 (de)
KR (1) KR950010150B1 (de)
AT (1) ATE67406T1 (de)
AU (1) AU594266B2 (de)
CA (1) CA1285485C (de)
DE (1) DE3773017D1 (de)
ES (1) ES2038605T3 (de)
GR (1) GR3003355T3 (de)
HK (1) HK65193A (de)
SG (1) SG64693G (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6351326A (ja) * 1986-08-22 1988-03-04 Nisshin Flour Milling Co Ltd ニコランジル外用剤
CA1336963C (en) * 1988-07-18 1995-09-12 Gary James Grover Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion
DE69720602T2 (de) * 1996-06-24 2004-02-12 Tosoh Corp., Shinnanyo Enzymsubstrat
SE9803517D0 (sv) * 1998-10-15 1998-10-15 Astra Ab Pharmaceutical preparation
US6417207B1 (en) * 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US20040235163A1 (en) * 2001-08-22 2004-11-25 Mitsuhiro Yokota Myocardial cell apoptosis inhibitors
CN100417381C (zh) * 2006-02-09 2008-09-10 西安力邦医药科技有限责任公司 尼可地尔冻干粉的制备方法
CN101474161B (zh) * 2009-01-14 2011-11-16 北京四环科宝制药有限公司 尼可地尔冻干粉针剂及其制备方法
WO2013002382A1 (ja) * 2011-06-30 2013-01-03 持田製薬株式会社 ニコランジル含有医薬組成物
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法
CN111574441B (zh) * 2020-05-26 2021-12-31 中国科学院上海药物研究所 一种尼可地尔与水杨酸的共晶及其制备方法和应用
CN111606847B (zh) * 2020-05-26 2021-12-31 中国科学院上海药物研究所 尼可地尔与1-羟基-2-萘甲酸的共晶及其制备方法和应用
CN115624527A (zh) * 2022-09-20 2023-01-20 朗天药业(湖北)有限公司 一种尼可地尔冻干粉针剂及其制备方法和用途
CN115487156A (zh) * 2022-10-17 2022-12-20 南京正科医药股份有限公司 一种注射用尼可地尔粉针剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168438A (en) * 1962-08-09 1965-02-02 Synergistics Inc Vasodilation by nitric acid ester derivatives of nicotinic acid
US3332848A (en) * 1963-07-10 1967-07-25 Hoffmann La Roche Microcrystalline cellulose with starch in niacinamide ascorbic acid tablet granulations
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
JPS56139414A (en) * 1980-04-01 1981-10-30 Dai Ichi Seiyaku Co Ltd Stabilizing method of aqueous solution
JPS5727087A (en) * 1980-07-25 1982-02-13 Toshiba Corp Wavelength sweeping laser
ATE22530T1 (de) * 1980-07-29 1986-10-15 Sanofi Sa Durch saeure stabilisierte mischungen von thienopyridinderivaten und verfahren zum verhindern der zersetzung solcher verbindungen.
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
JPS5762284A (en) * 1980-10-01 1982-04-15 Sumitomo Chem Co Ltd Stabilizing method
US4382091A (en) * 1981-04-30 1983-05-03 Syntex (U.S.A.) Inc. Stabilization of 1-substituted imidazole derivatives in talc
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60185727A (ja) * 1984-03-05 1985-09-21 Sumitomo Chem Co Ltd ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法

Also Published As

Publication number Publication date
KR950010150B1 (ko) 1995-09-11
AU6756287A (en) 1987-07-16
CA1285485C (en) 1991-07-02
US4769381A (en) 1988-09-06
SG64693G (en) 1993-08-06
EP0236679A1 (de) 1987-09-16
DE3773017D1 (de) 1991-10-24
JPS62252722A (ja) 1987-11-04
GR3003355T3 (en) 1993-02-17
EP0236679B1 (de) 1991-09-18
ES2038605T3 (es) 1993-08-01
HK65193A (en) 1993-07-16
JPH0713018B2 (ja) 1995-02-15
AU594266B2 (en) 1990-03-01
KR870006892A (ko) 1987-08-13

Similar Documents

Publication Publication Date Title
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
NO883229D0 (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
ZA885192B (en) Pharmaceutical preparations
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
ATE67406T1 (de) Nicorandil enthaltende zubereitung zum einspritzen.
SE8403487D0 (sv) Farmaceutisk komposition
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
ES8307210A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1, omega-difenil-aza-alcano.
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
ES466940A1 (es) Procedimiento para la obtencion de derivados de 6-etoxi-1,2 -dihidro-2,2,4-trimetilquinolina.
DE69005398D1 (de) Topisch kosmetisch anzuwendende depolymerisierte Nukleinsäuren enthaltende Arzneizubereitungen.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
KR910016734A (ko) 광학활성 알킬렌디옥시벤젠 유도체 및 치료에의 용도
JPS5363375A (en) Preparation of substd. benzoic acid amide derivatives
JPS6456622A (en) Percutaneous absorbefacient base composition
JPS52111576A (en) Synthesis of 5,7,8-trimethyl-3,4-dehydrotocotrienol
MY101266A (en) Pharmaceutical formulations
GB1449404A (en) N-arylsulphonyl urea derivatives
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
ES8608861A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time